ACRS icon

Aclaris Therapeutics
ACRS

Overview Fund Activity

133 hedge funds and large institutions have $737M invested in Aclaris Therapeutics in 2023 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 53 increasing their positions, 40 reducing their positions, and 27 closing their positions.

Holders
133
Holders Change
-15
Holders Change %
-10.14%
% of All Funds
2.1%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.08%
New
12
Increased
53
Reduced
40
Closed
27
Calls
$13M
Puts
$16.5M
Net Calls
-$3.45M
Net Calls Change
-$9.97M

Top Buyers

1
Morgan Stanley
1
Morgan Stanley
New York
$17M
2
Millennium Management
2
Millennium Management
New York
$8.58M
3
GPP
3
Great Point Partners
Connecticut
$20.1M
4
LGM
4
Logos Global Management
California
$5.44M
5
BlackRock
5
BlackRock
New York
$58M

Top Sellers

1
DTC
1
Deep Track Capital
Connecticut
$0
2
LCM
2
Laurion Capital Management
New York
$0
3
CC
3
Commodore Capital
New York
$0
4
Citadel Advisors
4
Citadel Advisors
Florida
$27.1M
5
OCA
5
Octagon Capital Advisors
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Handelsbanken Fonder
151
Handelsbanken Fonder
Sweden
– -$120K -14,800 Closed
PA
152
Profund Advisors
Maryland
– -$112K -13,869 Closed
Voloridge Investment Management
153
Voloridge Investment Management
Florida
– -$91.8K -11,349 Closed
HCA
154
Hyperion Capital Advisors
New York
– -$87.9K -10,861 Closed
CC
155
Corton Capital
Ontario, Canada
– -$84.3K -10,419 Closed
QT
156
Quantbot Technologies
New York
– -$70.4K -8,700 Closed
Amundi
157
Amundi
France
– -$34.4K -3,975 Closed
TWA
158
TCI Wealth Advisors
Arizona
– -$4.27K -528 Closed
MPWT
159
MassMutual Private Wealth & Trust
Connecticut
– -$574 -71 Closed
3 4 5 6
7